These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 17827966)

  • 1. Cost-minimization analysis comparing topiramate with standard treatments in migraine prophylaxis.
    Ergun H; Gulmez SE; Tulunay FC
    Eur Neurol; 2007; 58(4):215-7. PubMed ID: 17827966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment.
    Brown JS; Papadopoulos G; Neumann PJ; Friedman M; Miller JD; Menzin J
    Headache; 2005 Sep; 45(8):1012-22. PubMed ID: 16109115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of topiramate in the prevention of migraines in the United States: an update.
    Brown JS; Rupnow MF; Neumann P; Friedman M; Menzin J
    Manag Care Interface; 2006 Dec; 19(12):31-8. PubMed ID: 17274479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate: new indication. Migraine prevention: best avoided.
    Prescrire Int; 2006 Aug; 15(84):132-3. PubMed ID: 16989025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two center, randomized pilot study of migraine prophylaxis comparing paradigms using pre-emptive frovatriptan or daily topiramate: research and clinical implications.
    Cady RK; Voirin J; Farmer K; Browning R; Beach ME; Tarrasch J
    Headache; 2012 May; 52(5):749-64. PubMed ID: 22188311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate in migraine prophylaxis: long-term impact on resource utilization and cost.
    Silberstein SD; Feliu AL; Rupnow MF; Blount AC; Boccuzzi SJ
    Headache; 2007 Apr; 47(4):500-10. PubMed ID: 17445099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate in migraine prevention: evidence-based medicine from clinical trials.
    Silberstein SD
    Neurol Sci; 2004 Oct; 25 Suppl 3():S244-5. PubMed ID: 15549548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of migraine prevention: the case of topiramate in the UK.
    Brown JS; Papadopoulos G; Neumann PJ; Price M; Friedman M; Menzin J
    Cephalalgia; 2006 Dec; 26(12):1473-82. PubMed ID: 17116098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate for migraine prophylaxis.
    Drug Ther Bull; 2006 Aug; 44(8):62-4. PubMed ID: 16903488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials.
    Bussone G; Diener HC; Pfeil J; Schwalen S
    Int J Clin Pract; 2005 Aug; 59(8):961-8. PubMed ID: 16033621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate for migraine prevention in adolescents: a pooled analysis of efficacy and safety.
    Winner P; Gendolla A; Stayer C; Wang S; Yuen E; Battisti WP; Nye JS
    Headache; 2006; 46(10):1503-10. PubMed ID: 17115983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate in migraine prophylaxis: data from a pooled analysis and open-label extension study.
    Bussone G; Usai S; D'Amico D
    Neurol Sci; 2006 May; 27 Suppl 2():S159-63. PubMed ID: 16688622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate for migraine prevention.
    Wenzel RG; Schwarz K; Padiyara RS
    Pharmacotherapy; 2006 Mar; 26(3):375-87. PubMed ID: 16503717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
    Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate in the prophylactic treatment of migraine in children.
    Campistol J; Campos J; Casas C; Herranz JL
    J Child Neurol; 2005 Mar; 20(3):251-3. PubMed ID: 15832623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, one-year clinical trial comparing the efficacy of topiramate, flunarizine, and a combination of flunarizine and topiramate in migraine prophylaxis.
    Luo N; Di W; Zhang A; Wang Y; Ding M; Qi W; Zhu Y; Massing MW; Fang Y
    Pain Med; 2012 Jan; 13(1):80-6. PubMed ID: 22233396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate in Migraine Prevention: A 2016 Perspective.
    Silberstein SD
    Headache; 2017 Jan; 57(1):165-178. PubMed ID: 27902848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of migraine prophylaxis on migraine-related resource use and productivity.
    Láinez MJ
    CNS Drugs; 2009 Sep; 23(9):727-38. PubMed ID: 19689164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.